Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells

Phthalates are widely used as plasticizers. Humans can be exposed to phthalates through ingestion, inhalation, or treatments that release di(2-ethylhexyl) phthalate (DEHP) and its metabolite, mono(2-ehylhexyl) phthalate (MEHP), into the body from polyvinyl chloride-based medical devices. Phthalate exposure may induce reproductive toxicity, liver damage, and carcinogenesis in humans. This study found that colon cancer cells exposed to DEHP or MEHP exhibited increased cell viability and increased levels of P-glycoprotein, CD133, Bcl-2, Akt, ERK, GSK3β, and β-catenin when treated with oxaliplatin or irinotecan, as compared to control. The P-glycoprotein inhibitor, tariquidar, which blocks drug efflux, reduced the viability of DEHP- or MEHP-treated, anti-cancer drug-challenged cells. DEHP or MEHP treatment also induced colon cancer cell migration and epithelial-mesenchymal transformation. Elevated stemness-related protein levels (β-catenin, Oct4, Sox2, and Nanog) and increased cell sphere sizes indicated that DEHP- or MEHP-treated cells were capable of self-renewal. We also found that serum DEHP concentrations were positively correlated with cancer recurrence. These results suggest phthalate exposure enhances colon cancer cell metastasis and chemotherapeutic drug resistance by increasing cancer cell stemness, and that P-glycoprotein inhibitors might improve outcomes for advanced or drug-resistant colon cancer patients.

[1]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[2]  I. Pastan,et al.  Expression of Multidrug Resistance Gene in Human Cancers , 1989 .

[3]  Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice. , 1997, National Toxicology Program technical report series.

[4]  B. Lake,et al.  A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. , 1999, Regulatory toxicology and pharmacology : RTP.

[5]  S. Hirohashi,et al.  Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. , 2000, Cancer research.

[6]  M. Pallis,et al.  P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. , 2000, Blood.

[7]  T. Schettler,et al.  Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. , 2001, American journal of industrial medicine.

[8]  B. Demoré,et al.  Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solution , 2002, Journal of clinical pharmacy and therapeutics.

[9]  R. Henderson,et al.  NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. , 2002, Reproductive toxicology.

[10]  M. K. Chourasia,et al.  Pharmaceutical approaches to colon targeted drug delivery systems. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[11]  G. Presta,et al.  In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. , 2003, Environmental health perspectives.

[12]  Takashi Tsuruo,et al.  Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal , 2003, Cancer science.

[13]  W. Huttner,et al.  Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer , 2004, Cell and Tissue Research.

[14]  Antonia M. Calafat,et al.  Use of Di(2-ethylhexyl) Phthalate–Containing Medical Products and Urinary Levels of Mono(2-ethylhexyl) Phthalate in Neonatal Intensive Care Unit Infants , 2005, Environmental health perspectives.

[15]  H. Heinzl,et al.  Transfusion‐related exposure to the plasticizer di(2‐ethylhexyl)phthalate in patients receiving plateletpheresis concentrates , 2005, Transfusion.

[16]  A. Takeshita,et al.  The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells. , 2006, The Journal of endocrinology.

[17]  A. Calafat,et al.  Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans. , 2006, Toxicology.

[18]  L. Andĕra,et al.  Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? , 2007, Biochemical and biophysical research communications.

[19]  Yuki Ito,et al.  Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor alpha-independent pathway. , 2007, Journal of occupational health.

[20]  C. D. Salcido,et al.  Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.

[21]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[22]  K. Mimori,et al.  Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer , 2008, Annals of Surgical Oncology.

[23]  K. Mimori,et al.  CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells , 2008, Annals of Surgical Oncology.

[24]  K. Chan,et al.  Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.

[25]  Mei-Lien Chen,et al.  The internal exposure of Taiwanese to phthalate--an evidence of intensive use of plastic materials. , 2008, Environment international.

[26]  N. Zilembo,et al.  Oxaliplatin doublets in non-small cell lung cancer: a literature review. , 2008, Lung cancer.

[27]  Jin-xiang Cheng,et al.  How powerful is CD133 as a cancer stem cell marker in brain tumors? , 2009, Cancer treatment reviews.

[28]  Haitao Zhu,et al.  Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells. , 2009, Oncology reports.

[29]  Linda J. M. Oostendorp,et al.  Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer , 2010, Anti-cancer drugs.

[30]  Sun-Hee Kim,et al.  TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases , 2010, Molecular Cancer.

[31]  Zhen Liu,et al.  Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines. , 2010, Chinese journal of cancer.

[32]  S. Ambudkar,et al.  Improving cancer chemotherapy with modulators of ABC drug transporters. , 2011, Current drug targets.

[33]  Leina Ma,et al.  MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. , 2011, Cancer letters.

[34]  T. Alcindor,et al.  Drug Development in Contemporary Oncology Methods of Study Selection , 2022 .

[35]  M. Wong,et al.  The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response , 2011, Cancers.

[36]  C. di Ilio,et al.  The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. , 2011, Journal of biological regulators and homeostatic agents.

[37]  Y. Ko,et al.  Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  Jorng-Tzong Horng,et al.  Evaluation of the Appropriate Age Range of Colorectal Cancer Screening Based on the Changing Epidemiology in the Past 20 Years in Taiwan , 2012, ISRN gastroenterology.

[39]  J. Richburg,et al.  Mono-(2-Ethylhexyl) Phthalate (MEHP) Promotes Invasion and Migration of Human Testicular Embryonal Carcinoma Cells1 , 2012, Biology of reproduction.

[40]  Shao-Chun Wang,et al.  Phthalates induce proliferation and invasiveness of estrogen receptor‐negative breast cancer through the AhR/HDAC6/c‐Myc signaling pathway , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  R. Parks,et al.  Surgery for Colorectal Liver Metastases , 2013, Digestive Surgery.

[42]  Yung-Kuo Lee,et al.  Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal Carcinoma , 2013, PloS one.

[43]  Y. Liu,et al.  Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells , 2013, Proceedings of the National Academy of Sciences.

[44]  P. Chakraborty,et al.  Pituitary homeobox 2 (PITX2) protects renal cancer cell lines against doxorubicin toxicity by transcriptional activation of the multidrug transporter ABCB1 , 2013, International journal of cancer.

[45]  M. Gütschow,et al.  Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin. , 2013, Pharmazie.

[46]  J. Shimazaki,et al.  Complete response of lung metastases from rectal cancer to combination first-line therapy of S-1 and irinotecan plus bevacizumab: A case report and review of the literature , 2014, Oncology letters.

[47]  X. Pivot,et al.  Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review , 2014, Cancer medicine.

[48]  M. Maríc,et al.  Leaching of the plasticizer di(2-ethylhexyl)phthalate (DEHP) from plastic containers and the question of human exposure , 2014, Applied Microbiology and Biotechnology.

[49]  F-P Chen,et al.  Lower concentrations of phthalates induce proliferation in human breast cancer cells , 2014, Climacteric : the journal of the International Menopause Society.

[50]  S. Anderson,et al.  Potential Health Effects Associated with Dermal Exposure to Occupational Chemicals , 2014, Environmental health insights.

[51]  T. Hansen,et al.  Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature , 2015, Acta oncologica.

[52]  S. Nam,et al.  Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53 , 2015, Cell Death and Disease.

[53]  U. Şireli,et al.  In Vitro Effects of Phthalate Mixtures on Colorectal Adenocarcinoma Cell Lines. , 2015, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[54]  N. Kim,et al.  Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis , 2016, Annals of Surgical Oncology.

[55]  Dong Wang,et al.  Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis , 2015, BMC Cancer.

[56]  Philip E Mirkes,et al.  Assessment of phthalates/phthalate alternatives in children’s toys and childcare articles: Review of the report including conclusions and recommendation of the Chronic Hazard Advisory Panel of the Consumer Product Safety Commission , 2015, Journal of Exposure Science and Environmental Epidemiology.

[57]  Chia-Yi Hsu,et al.  Curcumin Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular Carcinoma. , 2015, Journal of agricultural and food chemistry.

[58]  S. Barni,et al.  Efficacy of Oxaliplatin-based Chemotherapy+Bevacizumab as First-line Treatment for Advanced Colorectal Cancer: A Systematic Review and Pooled Analysis of Published Trials , 2015, American journal of clinical oncology.

[59]  M. Gottesman,et al.  Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein , 2016, Drug Metabolism and Disposition.

[60]  W. Shi,et al.  Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma. , 2016, Pathology, research and practice.

[61]  E. Tsai,et al.  Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling , 2016, Oncotarget.

[62]  G. Lin,et al.  Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer , 2016, Data in brief.

[63]  C. Selvasekar,et al.  Validation of nomogram for disease free survival for colon cancer in UK population: A prospective cohort study. , 2016, International journal of surgery.

[64]  M. Pan,et al.  Effects of di(2-ethylhexyl)phthalate exposure on 1,2-dimethyhydrazine-induced colon tumor promotion in rats. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[65]  Ray-Jade Chen,et al.  Inhibition of NF‐κB and metastasis in irinotecan (CPT‐11)‐resistant LoVo colon cancer cells by thymoquinone via JNK and p38 , 2017, Environmental toxicology.

[66]  V. Borromeo,et al.  Maternal exposure to di(2‐ethylhexyl)phthalate (DEHP) promotes the transgenerational inheritance of adult‐onset reproductive dysfunctions through the female germline in mice , 2017, Toxicology and applied pharmacology.